Events
PharmaMar has presented data from the Phase IV NIMES-ROC clinical trial with its marine-derived anti-tumor compound, Yondelis®, at the European Congress of Oncological Gynecology, being held from 2-5 November in Athens, Greece..
Preclinical results support the therapeutic potential of KB-1801 for the prevention of Cardiac Surgery-Associated Acute Kidney Injury and advancement into clinical development
Certara will host two Phoenix WinNonlin™ Lunch and Learns and also lead 18 workshop, presentation and poster sessions on model-informed drug development
Esperion announced that pooled analyses from four Phase 3 clinical trials of bempedoic acid will be presented at the American Heart Association Scientific Sessions in Philadelphia on Sunday, November 17, 2019.
Company to Highlight Potential of Phase 3 Precision Antibiotic Ridinilazole at the 7th Annual C. diff. Conference and Health EXPO
Presentations demonstrate how to employ real-world evidence to compare the cost-effectiveness and therapeutic benefit of different medical interventions
A key focus of the Sensors USA part of the IDTechEx Show! will be Point-of-Care Biosensors.
A shortage of qualified personnel may be a drag factor in cell and gene therapies; in China 100,00L of capacity will need to be added every year to meet bio demand
Keynote addresses industry shifts based on recent advancements in monoclonal antibody drug manufacturing
Visit booth 4631 to see disposable and sterile needles for the delivery of anesthetic
PRESS RELEASES